ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,144, issued on Nov. 18, was assigned to AMNEAL PHARMACEUTICALS LLC (Bridgewater, N.J.).
"Pharmaceutical composition comprising eliglustat" was invented by Parva Yogeshchandra Purohit (Ahmedabad, India), Paras Rasiklal Vasanani (Ahmedabad, India), Vikas Maheshbhai Agrawal (Ahmedabad, India), Kishan Pradipbhai Suchak (Ahmedabad, India) and Sandip Pareshbhai Mehta (Ahmedabad, India).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition comprising glucosylceramide synthase inhibitor and a one or more pharmaceutically acceptable excipients. The present invention specifically relates to a sublingual ph...